BioWorld MedTech

March 29, 2017

Organogenesis moves into amniotic tissue market with acquisition of Nutech Medical

Organogenesis Inc. is set to acquire Nutech Medical Inc. a private company and supplier of tissue products used in spinal and orthopedic surgeries. Financial details surrounding the deal were not disclosed. Read More

Shuren: Single device review program at top of harmonization list

The OECD sounds the alarm about medical devices on the European market

L.A. biopharma ramping up for clinical phase

Appointments and advancements

Daily M&A

Financings

Other news to note

Product briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...